BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10065427)

  • 1. [A risk analysis of congenital defects due to drug intake during pregnancy. Spanish Collaborative Study of Congenital Malformations].
    Martínez-Frías ML
    Med Clin (Barc); 1999 Jan; 112(2):41-4. PubMed ID: 10065427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal periconceptional illicit drug use and the risk of congenital malformations.
    van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
    Epidemiology; 2009 Jan; 20(1):60-6. PubMed ID: 19057385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
    Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
    Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal smoking and congenital heart defects.
    Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
    Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study.
    van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
    Drug Alcohol Depend; 2010 Jun; 109(1-3):243-7. PubMed ID: 20171023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal flu or fever, medication use, and neural tube defects: a population-based case-control study in Northern China.
    Li Z; Ren A; Liu J; Pei L; Zhang L; Guo Z; Li Z
    Birth Defects Res A Clin Mol Teratol; 2007 Apr; 79(4):295-300. PubMed ID: 17216625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bedsharing and maternal smoking in a population-based survey of new mothers.
    Lahr MB; Rosenberg KD; Lapidus JA
    Pediatrics; 2005 Oct; 116(4):e530-42. PubMed ID: 16199682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of oral contraceptives in pregnancy and major structural birth defects in offspring.
    Waller DK; Gallaway MS; Taylor LG; Ramadhani TA; Canfield MA; Scheuerle A; Hernández-Diaz S; Louik C; Correa A;
    Epidemiology; 2010 Mar; 21(2):232-9. PubMed ID: 20087193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case-control study on influence factors of birth defects].
    Xiu XH; Yuan L; Wang XM; Chen YH; Wan AH; Fu P
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):481-6. PubMed ID: 22041437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal exposure to sex hormones: a case-control study.
    Martínez-Frías ML; Rodríguez-Pinilla E; Bermejo E; Prieto L
    Teratology; 1998 Jan; 57(1):8-12. PubMed ID: 9516746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periconceptional exposure to contraceptive pills and risk for Down syndrome.
    Martínez-Frías ML; Bermejo E; Rodríguez-Pinilla E; Prieto L
    J Perinatol; 2001; 21(5):288-92. PubMed ID: 11536021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors.
    Torfs CP; Velie EM; Oechsli FW; Bateson TF; Curry CJ
    Teratology; 1994 Jul; 50(1):44-53. PubMed ID: 7974254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case-control study.
    Martínez-Frías ML; Bermejo E; Rodríguez-Pinilla E; Frías JL
    Birth Defects Res A Clin Mol Teratol; 2004 Apr; 70(4):194-200. PubMed ID: 15108246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to salicylates and gastroschisis: a case-control study.
    Martínez-Frías ML; Rodríguez-Pinilla E; Prieto L
    Teratology; 1997 Oct; 56(4):241-3. PubMed ID: 9408974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal hormone therapy and congenital heart disease.
    Ferencz C; Matanoski GM; Wilson PD; Rubin JD; Neill CA; Gutberlet R
    Teratology; 1980 Apr; 21(2):225-39. PubMed ID: 7394725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based case-control study of the safety of oral anti-tuberculosis drug treatment during pregnancy.
    Czeizel AE; Rockenbauer M; Olsen J; Sørensen HT
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):564-8. PubMed ID: 11409585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants.
    Loffredo CA; Wilson PD; Ferencz C
    Teratology; 2001 Aug; 64(2):98-106. PubMed ID: 11460261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
    Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
    Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal drugs and the risk of selected birth defects.
    Carter TC; Druschel CM; Romitti PA; Bell EM; Werler MM; Mitchell AA;
    Am J Obstet Gynecol; 2008 Feb; 198(2):191.e1-7. PubMed ID: 18226621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study.
    Kjaer D; Horvath-Puhó E; Christensen J; Vestergaard M; Czeizel AE; Sørensen HT; Olsen J
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):181-8. PubMed ID: 16941718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.